Publications in collaboration with researchers from South Tees Hospitals NHS Foundation Trust (1)

2022

  1. Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

    Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1415-1427